Cat.nr.L1700
Een unieke collectie van 10524 bioactieve verbindingen voor high throughput screening (HTS) en high content screening (HCS).
Geciteerd door 425 Publicaties
• A unique collection of 10524 bioactive compounds for high throughput screening (HTS) and high content screening (HCS)
• Bioactivity and safety of some compounds confirmed by preclinical research and clinical trials
• Some compounds have been approved by the FDA
• Includes most Selleck inhibitors, APIs, natural products, and chemotherapeutic agents
• Structurally diverse, medicinally active, and cell permeable
• Rich documentation with structure and customer reviews
• NMR and HPLC validated to ensure high purity
| Formulering | 9758 compounds pre-dissolved in 10mM DMSO, 518 compounds pre-dissolved in 10mM water, 226 compounds pre-dissolved in 2mM DMSO, 20 compounds pre-dissolved in 2mM water and 2 compounds pre-dissolved in 2mg/ml DMSO | ||
|---|---|---|---|
| Container | 96 Deep Well Plaat verzegeld met aluminiumfolie | ||
| Stabiliteit | 12 months | -20°C | in DMSO |
| 24 months | -80°C | in DMSO | |
| Verzending | Koude elementen of droogijs | ||
Toepassing van GPCR Compound Library bij leverkanker (Dit artikel is gepubliceerd in Nature (IF
Toepassing van Kinase Inhibitor Library bij darmkanker (Dit artikel is gepubliceerd in Nature Communications (IF
Toepassing van FDA-approved Drug Library bij antivirus (Dit artikel is gepubliceerd in Cell Research (IF
Toepassing van FDA-approved Drug Library in metabolisme (Dit artikel is gepubliceerd in Movement Disorders (IF
Toepassing van Epigenetics Compound Library bij acute lymfatische leukemie (Dit artikel is gepubliceerd in Blood (IF
Toepassing van Inhibitor Library in tumorimmunologie (Dit artikel is gepubliceerd in Cancer Immunol Res (IF